Bactiguard Holding AB
STO:BACTI B

Watchlist Manager
Bactiguard Holding AB Logo
Bactiguard Holding AB
STO:BACTI B
Watchlist
Price: 15.95 SEK 1.59% Market Closed
Market Cap: kr495.1m

Relative Value

The Relative Value of one BACTI B stock under the Base Case scenario is 26.53 SEK. Compared to the current market price of 15.95 SEK, Bactiguard Holding AB is Undervalued by 40%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

BACTI B Relative Value
Base Case
26.53 SEK
Undervaluation 40%
Relative Value
Price
Worst Case
Base Case
Best Case

Multiples Across Competitors

BACTI B Competitors Multiples
Bactiguard Holding AB Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
SE
Bactiguard Holding AB
STO:BACTI B
495.1m SEK 2.2 -63.1 -180.4 -180.4
JP
Hoya Corp
TSE:7741
9.4T JPY 10.3 37.5 27.2 32.6
US
Medline Inc
NASDAQ:MDLN
57.3B USD 0 0 0 0
CH
Alcon AG
SIX:ALC
29B CHF 3.6 38.1 14.6 28.5
DK
Coloplast A/S
CSE:COLO B
96.9B DKK 3.5 24.4 12.9 15.4
US
Align Technology Inc
NASDAQ:ALGN
12.6B USD 3.1 30.7 13.2 18.1
CN
Intco Medical Technology Co Ltd
SZSE:300677
40.1B CNY 3.9 22.8 34 34
UK
ConvaTec Group PLC
LSE:CTEC
4.4B GBP 2.4 33.5 11.7 18.3
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
39.3B CNY 8.6 23.8 21.4 21.4
CA
Bausch + Lomb Corp
NYSE:BLCO
5.7B USD 1.1 -15.8 17 55.1
JP
Asahi Intecc Co Ltd
TSE:7747
836.8B JPY 6.4 47.3 22.3 30.3
P/E Multiple
Earnings Growth PEG
SE
Bactiguard Holding AB
STO:BACTI B
Average P/E: 32.3
Negative Multiple: -63.1
N/A N/A
JP
Hoya Corp
TSE:7741
37.5
14%
2.7
US
M
Medline Inc
NASDAQ:MDLN
Not Available
29%
N/A
CH
Alcon AG
SIX:ALC
38.1
32%
1.2
DK
Coloplast A/S
CSE:COLO B
24.4
21%
1.2
US
Align Technology Inc
NASDAQ:ALGN
30.7
34%
0.9
CN
Intco Medical Technology Co Ltd
SZSE:300677
22.8
12%
1.9
UK
ConvaTec Group PLC
LSE:CTEC
33.5
41%
0.8
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
23.8
9%
2.6
CA
Bausch + Lomb Corp
NYSE:BLCO
Negative Multiple: -15.8 N/A N/A
JP
A
Asahi Intecc Co Ltd
TSE:7747
47.3
38%
1.2
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
SE
Bactiguard Holding AB
STO:BACTI B
Average EV/EBITDA: 19.4
Negative Multiple: -180.4
N/A N/A
JP
Hoya Corp
TSE:7741
27.2
12%
2.3
US
M
Medline Inc
NASDAQ:MDLN
Not Available
9%
N/A
CH
Alcon AG
SIX:ALC
14.6
9%
1.6
DK
Coloplast A/S
CSE:COLO B
12.9
6%
2.1
US
Align Technology Inc
NASDAQ:ALGN
13.2
14%
0.9
CN
Intco Medical Technology Co Ltd
SZSE:300677
34
51%
0.7
UK
ConvaTec Group PLC
LSE:CTEC
11.7
11%
1.1
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
21.4
13%
1.6
CA
Bausch + Lomb Corp
NYSE:BLCO
17
29%
0.6
JP
A
Asahi Intecc Co Ltd
TSE:7747
22.3
12%
1.9
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
SE
Bactiguard Holding AB
STO:BACTI B
Average EV/EBIT: 28.2
Negative Multiple: -180.4
N/A N/A
JP
Hoya Corp
TSE:7741
32.6
N/A N/A
US
M
Medline Inc
NASDAQ:MDLN
Not Available N/A N/A
CH
Alcon AG
SIX:ALC
28.5
27%
1.1
DK
Coloplast A/S
CSE:COLO B
15.4
7%
2.2
US
Align Technology Inc
NASDAQ:ALGN
18.1
21%
0.9
CN
Intco Medical Technology Co Ltd
SZSE:300677
34
24%
1.4
UK
ConvaTec Group PLC
LSE:CTEC
18.3
23%
0.8
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
21.4
11%
1.9
CA
Bausch + Lomb Corp
NYSE:BLCO
55.1
74%
0.7
JP
A
Asahi Intecc Co Ltd
TSE:7747
30.3
N/A N/A
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett